The Initial Exploration of Polidocanol Sclerotherapy for the Treatment of Axillary Osmidrosis: A Retrospective Study

多酚类酚 硬化疗法 医学 外科 回顾性队列研究
作者
Sunyuan Yao,Yantao Cai,Chenfang Zhu
出处
期刊:Dermatologic Surgery [Lippincott Williams & Wilkins]
卷期号:51 (3): 290-295 被引量:5
标识
DOI:10.1097/dss.0000000000004428
摘要

BACKGROUND: Axillary osmidrosis (AO) is a strong, unpleasant odor that originates from the apocrine axillary glands. Treatments of AO include surgical treatment and nonsurgical treatment. The surgical procedure yields effective results with a low recurrence rate but requires a longer recovery time and has more postoperative complications. Nonsurgical treatments are minimally invasive and safe, but short-term recurrence may occur in some cases. OBJECTIVE: Polidocanol sclerotherapy was first described for management of AO. This retrospective study explored the clinical efficacy in relieving symptom of AO assessed by AO severity using the axillary osmidrosis grading system and safety of polidocanol sclerotherapy in treating AO. PATIENTS AND METHODS: This retrospective study included 25 patients with AO single-site study, with 12 patients receiving polidocanol (1%) sclerotherapy (the polidocanol group) and 13 receiving botulinum toxin A (BTX-A) injection (the BTX-A group). The short-term efficacy (7 days after injection), the long-term efficacy (6 months after injection), the recurrence rate, and complications were compared between the 2 groups. A p-value of <0.05 was considered statistically significant. RESULTS: The short-term efficacies of polidocanol sclerotherapy and BTX-A injection were 100% and 69.2%, which was not clinically significant (p > .05), whereas their long-term efficacies were 100% and 46.2%, respectively (p < .05). The recurrence rates in the polidocanol and BTX-A groups were 25.0% and 84.6%, respectively (p < .05). The complications did not differ significantly between the 2 groups (p > .05). Although the short-term efficacy and complications were comparable between the 2 groups, the long-term efficacy of polidocanol sclerotherapy was superior to BTX-A injection. The polidocanol group has a lower recurrence rate than the BTX-A group. CONCLUSION: Polidocanol sclerotherapy may provide an effective and safe treatment with longer efficacy compared to toxin, which is an effective and safe option for AO treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
开朗含海完成签到,获得积分10
1秒前
2秒前
3秒前
wanci的应助被dandelion采纳,获得10
3秒前
yayaya完成签到 ,获得积分10
3秒前
韦智杰发布了新的文献求助10
4秒前
4秒前
玉玉玉米发布了新的文献求助10
4秒前
开朗含海发布了新的文献求助10
5秒前
风语村发布了新的文献求助10
5秒前
小姜完成签到 ,获得积分10
5秒前
taipingyang发布了新的文献求助10
6秒前
YangyangShi完成签到 ,获得积分10
6秒前
传奇3的应助被科研通管家采纳,获得10
7秒前
clevenx完成签到,获得积分10
7秒前
李爱国的应助被科研通管家采纳,获得10
7秒前
赘婿的应助被科研通管家采纳,获得10
7秒前
Owen的应助被科研通管家采纳,获得10
7秒前
小蘑菇的应助被科研通管家采纳,获得10
7秒前
君为臣纲的应助被科研通管家采纳,获得10
7秒前
无花果的应助被科研通管家采纳,获得10
7秒前
无花果的应助被科研通管家采纳,获得10
7秒前
小马甲的应助被科研通管家采纳,获得10
8秒前
Orange的应助被科研通管家采纳,获得10
8秒前
xy的应助被科研通管家采纳,获得30
8秒前
昭君出川完成签到,获得积分10
8秒前
8秒前
酷波er的应助被科研通管家采纳,获得10
8秒前
彭于晏的应助被科研通管家采纳,获得10
8秒前
8秒前
8秒前
在水一方的应助被科研通管家采纳,获得10
9秒前
yy完成签到,获得积分10
9秒前
CipherSage的应助被科研通管家采纳,获得10
9秒前
9秒前
瀚子完成签到,获得积分10
9秒前
耍酷的小刺猬完成签到 ,获得积分10
9秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194107
求助须知:如何正确求助?哪些是违规求助? 9580062
关于积分的说明 21869017
捐赠科研通 7793713
什么是DOI,文献DOI怎么找? 3437523
关于科研通互助平台的介绍 2560962
邀请新用户注册赠送积分活动 2484264